Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects (2004)
Chapter: Appendix B: Open Session and Workshop Agendas
B
Open Session and Workshop Agendas
Open Session
Monday, September 23, 2002
National Academy of Sciences
Room 105
2100 C Street, NW
Washington, DC
1:00 p.m. | Welcome, Introductions, and Purpose of the Public Session Bettie Sue Masters, Committee Chair |
Presentations from Representatives of the Sponsoring Agencies
1:10 | U.S. Department of Agriculture Michael Schechtman, Office of the Deputy Secretary Charles Edwards, Food Safety and Inspection Service |
2:10 | Food and Drug Administration Joseph Levitt, Center for Food Safety and Applied Nutrition James Maryanski, Center for Food Safety and Applied Nutrition |
3:10 | Break |
3:30 | U.S. Environmental Protection Agency J. Thomas McClintock, Office of Science Coordination and Policy |
4:30 | Open Discussion |
4:45 | Adjourn |
Workshop
Tuesday, January 7, 2003
Keck Building
Room 100
500 Fifth Street, NW
Washington, DC
8:30 a.m. | Welcome and Introductory Remarks Bettie Sue Masters, Committee Chair |
8:45 | Methods for Genetically Modifying Animals and Their Applications José Cibelli, Advanced Cell Technology, Inc. |
9:30 | Toxicity? Transgene Expression in Muscle as a Food Product Robert Schwartz, Baylor College of Medicine |
10:15 | Break |
10:30 | Determining Unintended Health Effects of Biotechnology-Derived Foods Ian Munro, CanTox, Inc. |
11:15 | Assessing Foods Derived from Genetically Modified Crops for Unintended Effects—an Industry Perspective Roy Fuchs, Monsanto Company |
12:00 noon | Lunch |
1:00 p.m. | Compositional Analyses of Foods and Feeds Derived from Biotechnology: A Lens into Unintended Effects Bruce Chassy, University of Illinois, Urbana-Champaign |
1:45 | The Use of Profiling Methods for Identification and Assessment of Unintended Effects in Genetically Modified Foods Harry Kuiper, RIKILT Wageningen University and Research Center, The Netherlands |
2:30 | Break |
2:45 | The International Life Sciences Institute Crop Composition Database Ray Shillito, Bayer CropScience |
3:30 | FDA Policy for Reviewing Genetically Engineered Crops: A Case-Study Assessment of FDA Oversight Douglas Gurian-Sherman, Center for Science in the Public Interest |
3:55 | Public Comment Session |
4:20 | Closing Remarks Bettie Sue Masters, Committee Chair |
4:30 | Adjourn |
